Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. GOOGL
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
(NASDAQ: IVVD) Delayed: 0.91 -0.06 (6.19%)
Previous Close $0.97    52 Week High $ 
Open $0.96    52 Week Low $ 
Day High $0.99    P/E N/A 
Day Low $0.91    EPS $ 
Volume 4,104,925